95 related articles for article (PubMed ID: 11280750)
1. Localization of a human reduced folate carrier protein in the mitochondrial as well as the cell membrane of leukemia cells.
Trippett TM; Garcia S; Manova K; Mody R; Cohen-Gould L; Flintoff W; Bertino JR
Cancer Res; 2001 Mar; 61(5):1941-7. PubMed ID: 11280750
[TBL] [Abstract][Full Text] [Related]
2. 5-amino-4-imidazolecarboxamide riboside potentiates both transport of reduced folates and antifolates by the human reduced folate carrier and their subsequent metabolism.
McGuire JJ; Haile WH; Yeh CC
Cancer Res; 2006 Apr; 66(7):3836-44. PubMed ID: 16585211
[TBL] [Abstract][Full Text] [Related]
3. Isolation of a gene encoding a human reduced folate carrier (RFC1) and analysis of its expression in transport-deficient, methotrexate-resistant human breast cancer cells.
Moscow JA; Gong M; He R; Sgagias MK; Dixon KH; Anzick SL; Meltzer PS; Cowan KH
Cancer Res; 1995 Sep; 55(17):3790-4. PubMed ID: 7641195
[TBL] [Abstract][Full Text] [Related]
4. Impaired membrane transport in methotrexate-resistant CCRF-CEM cells involves early translation termination and increased turnover of a mutant reduced folate carrier.
Wong SC; Zhang L; Witt TL; Proefke SA; Bhushan A; Matherly LH
J Biol Chem; 1999 Apr; 274(15):10388-94. PubMed ID: 10187828
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic and apoptotic effects of prenylflavonoid artonin B in human acute lymphoblastic leukemia cells.
Lee CC; Lin CN; Jow GM
Acta Pharmacol Sin; 2006 Sep; 27(9):1165-74. PubMed ID: 16923337
[TBL] [Abstract][Full Text] [Related]
6. Sequence alterations in the reduced folate carrier are observed in osteosarcoma tumor samples.
Yang R; Sowers R; Mazza B; Healey JH; Huvos A; Grier H; Bernstein M; Beardsley GP; Krailo MD; Devidas M; Bertino JR; Meyers PA; Gorlick R
Clin Cancer Res; 2003 Feb; 9(2):837-44. PubMed ID: 12576457
[TBL] [Abstract][Full Text] [Related]
7. Reduced folate carrier: tissue distribution and effects of chronic ethanol intake in the micropig.
Villanueva JA; Devlin AM; Halsted CH
Alcohol Clin Exp Res; 2001 Mar; 25(3):415-20. PubMed ID: 11290853
[TBL] [Abstract][Full Text] [Related]
8. Molecular events in the membrane transport of methotrexate in human CCRF-CEM leukemia cell lines.
Freisheim JH; Ratnam M; McAlinden TP; Prasad KM; Williams FE; Westerhof GR; Schornagel JH; Jansen G
Adv Enzyme Regul; 1992; 32():17-31. PubMed ID: 1323203
[TBL] [Abstract][Full Text] [Related]
9. Reduced folate carrier mutations are not the mechanism underlying methotrexate resistance in childhood acute lymphoblastic leukemia.
Kaufman Y; Drori S; Cole PD; Kamen BA; Sirota J; Ifergan I; Arush MW; Elhasid R; Sahar D; Kaspers GJ; Jansen G; Matherly LH; Rechavi G; Toren A; Assaraf YG
Cancer; 2004 Feb; 100(4):773-82. PubMed ID: 14770434
[TBL] [Abstract][Full Text] [Related]
10. Beauvericin induces cytotoxic effects in human acute lymphoblastic leukemia cells through cytochrome c release, caspase 3 activation: the causative role of calcium.
Jow GM; Chou CJ; Chen BF; Tsai JH
Cancer Lett; 2004 Dec; 216(2):165-73. PubMed ID: 15533592
[TBL] [Abstract][Full Text] [Related]
11. Genetic and epigenetic alterations of the reduced folate carrier in untreated diffuse large B-cell lymphoma.
Kastrup IB; Worm J; Ralfkiaer E; Hokland P; Guldberg P; Grønbaek K
Eur J Haematol; 2008 Jan; 80(1):61-6. PubMed ID: 18028428
[TBL] [Abstract][Full Text] [Related]
12. The reduced folate carrier gene is a novel selectable marker for recombinant protein overexpression.
Rothem L; Berman B; Stark M; Jansen G; Assaraf YG
Mol Pharmacol; 2005 Sep; 68(3):616-24. PubMed ID: 15939798
[TBL] [Abstract][Full Text] [Related]
13. Differential involvement of reactive oxygen species in apoptosis caused by the inhibition of protein phosphatase 2A in Jurkat and CCRF-CEM human T-leukemia cells.
Boudreau RT; Conrad DM; Hoskin DW
Exp Mol Pathol; 2007 Dec; 83(3):347-56. PubMed ID: 17936751
[TBL] [Abstract][Full Text] [Related]
14. Localization and partial characterization of a 60 kDa citrulline-containing transport form of myelin basic protein from MO3-13 cells and human white matter.
Ursell MR; McLaurin J; Wood DD; Ackerley CA; Moscarello MA
J Neurosci Res; 1995 Sep; 42(1):41-53. PubMed ID: 8531225
[TBL] [Abstract][Full Text] [Related]
15. Nuclear and plasma membrane localization of SH3BP4 in retinal pigment epithelial cells.
Khanobdee K; Kolberg JB; Dunlevy JR
Mol Vis; 2004 Dec; 10():933-42. PubMed ID: 15616480
[TBL] [Abstract][Full Text] [Related]
16. Modulation of ceramide metabolism in T-leukemia cell lines potentiates apoptosis induced by the cationic antimicrobial peptide bovine lactoferricin.
Furlong SJ; Ridgway ND; Hoskin DW
Int J Oncol; 2008 Mar; 32(3):537-44. PubMed ID: 18292930
[TBL] [Abstract][Full Text] [Related]
17. Reduced folate carrier protein expression in osteosarcoma: implications for the prediction of tumor chemosensitivity.
Ifergan I; Meller I; Issakov J; Assaraf YG
Cancer; 2003 Nov; 98(9):1958-66. PubMed ID: 14584080
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 inhibitors sensitize tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by uncoupling of mitochondrial respiration in human leukemic CEM cells.
Hao JH; Yu M; Liu FT; Newland AC; Jia L
Cancer Res; 2004 May; 64(10):3607-16. PubMed ID: 15150119
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a folate transporter in HeLa cells with a low pH optimum and high affinity for pemetrexed distinct from the reduced folate carrier.
Wang Y; Zhao R; Goldman ID
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6256-64. PubMed ID: 15448015
[TBL] [Abstract][Full Text] [Related]
20. The 44 kDa Pim-1 kinase directly interacts with tyrosine kinase Etk/BMX and protects human prostate cancer cells from apoptosis induced by chemotherapeutic drugs.
Xie Y; Xu K; Dai B; Guo Z; Jiang T; Chen H; Qiu Y
Oncogene; 2006 Jan; 25(1):70-8. PubMed ID: 16186805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
